Stay updated on Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial

Sign up to get notified when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study record for the dengue vaccine booster trial is displayed, including its study details, results, eligibility criteria, and supporting documents, in place of a 403 error page.
    Difference
    56%
    Check dated 2026-11-08T14:35:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:41:46.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The page itself still displays a 403 Forbidden error rather than the study record.
    Difference
    1%
    Check dated 2026-10-25T15:36:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The 403 error display is replaced by a mostly empty ClinicalTrials.gov study-page shell; the study record details are not visible.
    Difference
    0.6%
    Check dated 2026-10-18T22:02:11.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:13:02.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error screen, replacing the study content. It includes a 403 heading and minimal navigation (such as a Home link) along with a revision note, signaling that access to the record is blocked.
    Difference
    19%
    Check dated 2026-09-20T22:30:04.000Z thumbnail image

Stay in the know with updates to Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.